◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

Home › All stocks › STE

STERIS plc (STE) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-07-18

STERIS plc (STE) operates in the Health Care Equipment industry and is headquartered in Mentor, United States with about 17,937 employees. Its market capitalization is roughly $21 billion. In the fiscal year ended 2026-03-31, STE reported $5.9B in revenue and $785M in net income.

STERIS plc provides infection prevention products and services in the United States, Ireland, and internationally. It operates through three segments: Healthcare, Applied Sterilization Technologies, and Life Sciences.

Interactive charts & full statements → Open the STE valuation workbench →

STE Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-03-31	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Total Revenue	$5.9B	$5.9B	$5.5B	$5.1B	$4.5B	$4.2B	$3.1B	$3.0B	$2.8B	$2.6B	$2.6B	$2.2B	$1.9B	$1.6B	$1.5B	$1.4B	$1.2B	$1.3B	$1.3B	$1.3B	$1.2B
Gross Profit	$2.6B	$2.6B	$2.4B	$2.2B	$2.0B	$1.9B	$1.3B	$1.3B	$1.2B	$1.1B	$1.0B	$895M	$774M	$650M	$621M	$568M	$446M	$539M	$527M	$524M	$505M
Gross Margin %	44.2%	44.2%	44.0%	43.2%	43.7%	44.6%	43.2%	43.5%	42.2%	41.7%	39.3%	40.0%	41.9%	40.0%	41.4%	40.4%	37.0%	42.9%	40.6%	41.4%	42.2%
Operating Income (EBIT)	$1.1B	$1.1B	$867M	$836M	$791M	$478M	$548M	$537M	$411M	$400M	$226M	$213M	$227M	$207M	$243M	$222M	$85M	$204M	$175M	$124M	$138M
Operating Margin %	18.6%	18.6%	15.9%	16.3%	17.4%	11.3%	17.6%	17.7%	14.8%	15.3%	8.7%	9.5%	12.3%	12.8%	16.2%	15.8%	7.1%	16.2%	13.5%	9.8%	11.5%
Net Income	$782M	$785M	$615M	$378M	$107M	$244M	$397M	$408M	$304M	$291M	$110M	$111M	$135M	$129M	$160M	$136M	$51M	$128M	$111M	$77M	$82M
Net Margin %	13.2%	13.2%	11.3%	7.4%	2.4%	5.8%	12.8%	13.5%	10.9%	11.1%	4.2%	5.0%	7.3%	8.0%	10.7%	9.7%	4.2%	10.2%	8.5%	6.1%	6.9%
EBITDA	$1.8B	$1.6B	$1.4B	$1.4B	$1.2B	$1.0B	$774M	$736M	$640M	$584M	$417M	$358M	$320M	$283M	$312M	$286M	$140M	$261M	$236M	$202M	$205M
Earnings Per Share (EPS)	$7.93	$7.95	$6.20	$3.81	$1.07	$2.48	$4.63	$4.76	$3.56	$3.39	$1.28	$1.56	$2.25	$2.17	$2.72	$2.31	$0.85	$2.16	$1.86	$1.20	$1.25
Shares Outstanding (M)	98M	99M	99M	99M	100M	98M	86M	86M	85M	86M	86M	71M	60M	60M	59M	59M	60M	59M	59M	64M	66M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

STE Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	$1.6B	$1.5B	$1.5B	$1.4B	$1.5B	$1.4B	$1.3B	$1.3B
Gross Profit	$697M	$656M	$646M	$628M	$641M	$610M	$579M	$572M
Gross Margin %	43.9%	43.8%	44.2%	45.1%	43.3%	44.5%	43.5%	44.7%
Operating Income (EBIT)	$317M	$271M	$268M	$246M	$216M	$245M	$220M	$186M
Operating Margin %	19.9%	18.1%	18.4%	17.7%	14.6%	17.9%	16.5%	14.5%
Net Income	$220M	$193M	$192M	$177M	$146M	$174M	$150M	$145M
Net Margin %	13.9%	12.9%	13.1%	12.8%	9.8%	12.7%	11.3%	11.4%
EBITDA	$680M	$391M	$390M	$367M	$337M	$374M	$330M	$318M
Earnings Per Share (EPS)	$2.24	$1.95	$1.94	$1.80	$1.48	$1.75	$1.51	$1.46
Shares Outstanding (M)	98M	99M	99M	99M	99M	99M	99M	99M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

STE Free Cash Flow History

Cash flow	TTM → 2026-03-31	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Cash from Operations (CFO)	$1.3B	$1.3B	$1.1B	$973M	$757M	$685M	$690M	$591M	$540M	$458M	$424M	$255M	$246M	$210M	$228M	$149M	$118M	$225M	$167M	$143M	$96M
Capital Expenditures (CapEx)	$369M	$369M	$370M	$360M	$362M	$288M	$239M	$215M	$190M	$165M	$173M	$126M	$85M	$86M	$87M	$67M	$77M	$44M	$41M	$57M	$49M
Free Cash Flow (FCF)	$972M	$972M	$778M	$613M	$395M	$397M	$450M	$376M	$350M	$292M	$251M	$128M	$161M	$123M	$140M	$83M	$40M	$181M	$126M	$86M	$47M
FCF Margin %	16.4%	16.4%	14.2%	11.9%	8.7%	9.4%	14.5%	12.4%	12.6%	11.2%	9.6%	5.7%	8.7%	7.6%	9.3%	5.9%	3.3%	14.4%	9.7%	6.8%	3.9%
Dividends Paid	$242M	$242M	$220M	$201M	$183M	$163M	$134M	$123M	$113M	$103M	$93M	$65M	$54M	$48M	$43M	$39M	$33M	$144M	$18M	$15M	$12M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

STE Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Cash from Operations (CFO)	$335M	$298M	$288M	$420M	$261M	$333M	$251M	$304M
Capital Expenditures (CapEx)	$90M	$99M	$86M	$94M	$71M	$89M	$102M	$108M
Free Cash Flow (FCF)	$245M	$200M	$201M	$326M	$190M	$244M	$149M	$196M
FCF Margin %	15.4%	13.3%	13.8%	23.5%	12.8%	17.8%	11.2%	15.3%
Dividends Paid	$62M	$62M	$62M	$56M	$56M	$56M	$56M	$51M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

STE Balance Sheet History

Balance sheet	2026-03-31	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31	2020-03-31	2019-03-31	2018-03-31	2017-03-31	2016-03-31	2015-03-31	2014-03-31	2013-03-31	2012-03-31	2011-03-31	2010-03-31	2009-03-31	2008-03-31	2007-03-31
Total Assets	$10.7B	$10.7B	$10.1B	$11.1B	$10.8B	$11.4B	$6.6B	$5.4B	$5.1B	$5.2B	$4.9B	$5.3B	$2.1B	$1.9B	$1.8B	$1.4B	$1.4B	$1.2B	$1.2B	$1.2B	$1.2B
Cash & Cash Equivalents	$440M	$440M	$172M	$207M	$208M	$348M	$221M	$320M	$221M	$202M	$283M	$249M	$168M	$153M	$142M	$151M	$193M	$215M	$154M	$52M	$52M
Total Liabilities	$3.5B	$3.5B	$3.5B	$4.7B	$4.7B	$4.9B	$2.7B	$2.0B	$1.9B	$2.0B	$2.1B	$2.3B	$1.0B	$846M	$814M	$583M	$638M	$484M	$499M	$533M	$435M
Total Debt (Short + Long-Term)	$2.0B	$2.0B	$2.1B	$3.2B	$3.1B	$3.1B	$1.7B	$1.2B	$1.2B	$1.4B	$1.5B	$1.6B	$658M	$533M	$532M	$228M	$210M	$210M	$210M	$180M	$102M
Total Shareholders' Equity	$7.2B	$7.2B	$6.6B	$6.3B	$6.1B	$6.5B	$3.9B	$3.4B	$3.2B	$3.2B	$2.8B	$3.0B	$1.1B	$1.0B	$947M	$821M	$788M	$754M	$718M	$706M	$774M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive STE viewer.

Other Companies in Health Care Equipment

IDXX · Idexx Laboratories — $43 billion
RMD · ResMed — $28 billion
DXCM · Dexcom — $28 billion
GEHC · GE HealthCare — $28 billion
ZBH · Zimmer Biomet — $18 billion
RVTY · Revvity — $12 billion
BAX · Baxter International — $12 billion
PODD · Insulet Corporation — $11 billion

← STC All stocks STEM →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.